期刊文献+

临床指标判定糖尿病肾病诊断与预后价值与局限性 被引量:12

Application of clinical parameters in the diagnosis and prognosis evaluation of diabetic nephropathy:values and limitations
原文传递
导出
摘要 糖尿病肾病是糖尿病主要的并发症,已成为终末期肾脏病的主要病因之一。糖尿病合并肾脏损害有很大比例是非糖尿病性肾脏疾病,两者的治疗和预后明显不同,因此早期诊断对改善预后尤为重要。综合应用年龄、糖尿病病程、糖尿病视网膜病变、血压、血糖等临床指标有助于两者的鉴别诊断及判断预后,但单纯应用临床指标仍存在一定局限性,对怀有疑问的病例仍需依靠肾活检进行确诊。新型生物标志物的临床应用价值还须进一步验证。 Summary:As one of the complications of diabetic mellitus, diabetic nephropathy (DN) has been the main cause of end stage renal disease. It is of great importance to diagnose DN early and accurately as other types of glomerulopathy occurs in- dependently or in parallel with diabetic nephropathy. Previous literatures have reported the role of several clinical factors in diagnosing DN and evaluating the progression of diabetic kidney disease,including age ,diabetes duration, diabetic retinopa- thy, hypertension, higher HbA1 c, et al. But the value of these clinical factors is still controversial and limited. Renal biopsy is required for the final diagnosis of suspicious patients. New biomarkers available need further confirmation in the diagnosis and evaluation of prognosis of diabetic nephropathy.
作者 蔡广研 梁爽
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2012年第6期405-407,共3页 Chinese Journal of Practical Internal Medicine
关键词 糖尿病肾病 非糖尿病性肾脏疾病 标志物 血糖 视网膜 血压 diabetic nephropathy non-diabetic renal disease biomarkers blood sugar retina blood pressure
  • 相关文献

参考文献9

  • 1Suzuki D,Takano H,Toyoda M,et al.Evaluation of renal biopsy samples of patients with diabetic nephropathy[].Journal of Internal Medicine.2001
  • 2Jianhui Zhou,Xiangmei Chen,Yuansheng Xie,et al.A differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases[].Nephrology Dialysis Transplantation.2008
  • 3Kveder R,Kajtna-Koselj M,Rott T,et al.Nephrotic syndrome in patients with diabetes mellitus is not always associated with diabetic nephropathy[].Nephrology Dialysis Transplantation.2001
  • 4LD Bash,E Selvin,M Steffes.Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) study[].Archives of Internal Medicine.2008
  • 5Action to Control Cardiovascular Risk in Diabetes Study Group,Gerstein HC,Miller ME,Byington RP,Goff DC Jr,Bigger JT,Buse JB,Cushman WC,Genuth S,Ismail-Beigi F,Grimm RH Jr,Probstfield JL,Simons-Morton DG,Friedewald WT.Effects of intensive glucose lowering in type 2 diabetes[].The New England Journal of Medicine.2008
  • 6Miao Y,Ottenbros SA,Laverman GD,et al.Effect of a reduction in uric acid on renal outcomes during losartan treatment:a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial[].Journal of Hypertension.2011
  • 7Altemtam N,Russell J,Nahas M.A study of the natural history of di-abetic kidney disease(DKD)[].Nephrology Dialysis Transplantation.2011
  • 8Lorenzo V,Saracho R,Zamora J,et al.Similar renal decline in dia-betic and non-diabetic patients with comparable levels of albuminu-ria[].Nephrology Dialysis Transplantation.2010
  • 9Iliadis F,Didangelos T,Ntemka A,et al.Glomerular filtration rateestimation in patients with type 2 diabetes:creatinine-or cystatin C-based equations?[].Diabetologia.2011

同被引文献103

引证文献12

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部